Cargando…
Reversible Linkage of Two Distinct Small Molecule Inhibitors of Myc Generates a Dimeric Inhibitor with Improved Potency That Is Active in Myc Over-Expressing Cancer Cell Lines
We describe the successful application of a novel approach for generating dimeric Myc inhibitors by modifying and reversibly linking two previously described small molecules. We synthesized two directed libraries of monomers, each comprised of a ligand, a connector, and a bioorthogonal linker elemen...
Autores principales: | Wanner, Jutta, Romashko, Darlene, Werner, Douglas S., May, Earl W., Peng, Yue, Schulz, Ryan, Foreman, Kenneth W., Russo, Suzanne, Arnold, Lee D., Pingle, Maneesh, Bergstrom, Donald E., Barany, Francis, Thomson, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398458/ https://www.ncbi.nlm.nih.gov/pubmed/25875098 http://dx.doi.org/10.1371/journal.pone.0121793 |
Ejemplares similares
-
MYC inhibitors in multiple myeloma
por: Martínez-Martín, Sandra, et al.
Publicado: (2021) -
MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015) -
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
por: Li, Weiping, et al.
Publicado: (2019) -
Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018) -
Target-Directed Self-Assembly of Homodimeric Drugs
Against β-Tryptase
por: Giardina, Sarah F., et al.
Publicado: (2018)